Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Clinical trial NCT04375800 · RECRUITING
Trial details
- NCT number
- NCT04375800
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-03
- Primary completion
- 2028-11-12
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.